Capital Cardiovascular Conference

Interventional cardiology and peripheral vascular interventional therapy

• continue to evolve with the rapid growth of new techniques and available technology. As practicing interventional physicians, we must continually make changes in how we treat coronary and peripheral vascular disease even as we have to contend with reimbursement and billing issues, turf battles, the potential for malpractice litigation and the real need to participate in continuing education to remain current.

Conscious of your valuable time

• We at C3 strive to present concise, significant information that will update you on the latest techniques and technologies and help clarify areas of diagnostic and therapeutic controversy. C3 2008 will include cases and panel symposia that cover:

• the treatment of carotid, femoral and infrapopliteal vascular disease,
• available drug-eluting stent platforms,
• the treatment of coronary CTO, left main and bifurcation coronary lesions,
• atherectomy devices,
• management of AMI and ACS,
• and management of thrombus, deep vein thrombosis and structural heart disease.
•  
• C3’s case-driven approach utilizes a proven effective teaching tool that makes the most of expert insight into the complex procedures that we regularly encounter. The 2008 program will cover the latest in percutaneous interventional therapies through satellite-transmitted live case demonstrations from multinational centers of excellence performed by leaders in the field. Complemented by unbiased commentary by world-renowned experts and discussions intended to bring about consensus through serious debate, the live cases demonstrate approaches and techniques that you can apply immediately in your practice.
•  
• New for 2008, C3 will feature concurrent sessions on fundamentals of cardiovascular medicine that will supplement the live cases with an up-to-date, comprehensive review of the most important and controversial topics of the current year. To optimize your learning experience, we have invited noted authorities to engage in lively panel discussions that will expand your already-firm knowledge base.
•  
• We offer C3 as a platform for continued innovation in interventional cardiovascular medicine, and I am confident that C3 2008 will positively affect how you practice medicine in the best interest of achieving excellent patient outcomes. I look forward to your joining us.
•  
• Sincerely,
• Rajesh Dave, M.D.
• Course Director

Why should you attend?

Why Should You Attend C³ 2008? Live cases to boost your knowledge exponentially Addressing technical, diagnostic and therapeutic dilemmas in every cardiovascular intervention subset, these hand-picked, educational cases are led by the most experienced operators from Europe, Asia and North America to power up your skills and understanding. (To view cases from C³ 2007, visit www.C3conference.net.) A no-holds-barred approach to controversy Debates during the live cases touch on hard-hitting questions of greatest importance to practitioners, and focused concurrent sessions cover the sensitive issues. Don’t pass up the opportunity to hear noted authorities and expert operators express their opinions. Real answers to your toughest treatment decisions With individual sessions focused on every cardiovascular disease state, you have an ideal forum for sharing your own cases. Bring along a CD with case information and a brief clinical history to see how the experts at C³ approach your problem.